Glenmark Pharmaceuticals submits media release

09 Jul 2019 Evaluate

Glenmark Pharmaceuticals has informed about submission of media release titled ‘Glenmark Pharmaceuticals receives ANDA approval for Ranolazine Extended?Release Tablets, 500 mg and 1,000 mg’ which is self explanatory. 

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1943.35 9.10 (0.47%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.55
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 876.10
Lupin 2139.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×